- Home
- SXTP
as 12-18-2024 4:00pm EST
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | WASHINGTON |
| Market Cap: | 1.6M | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 712.1K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.82 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.70 - $18.36 | Next Earning Date: | 11-14-2024 |
| Revenue: | $462,612 | Revenue Growth: | 128.99% |
| Revenue Growth (this year): | 267.05% | Revenue Growth (next year): | 181.82% |
Latest 60 Degrees Pharmaceuticals Inc. News
SXTP Breaking Stock News: Dive into SXTP Ticker-Specific Updates for Smart Investing
GlobeNewswire
7 days ago
60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital
ACCESSWIRE
16 days ago
VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ACCESSWIRE
a month ago
60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Zacks
a month ago
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates
GlobeNewswire
a month ago
60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results
GlobeNewswire
3 months ago
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch
MT Newswires
3 months ago
60 Degrees Pharmaceuticals Closes $4 Million Private Placement
GlobeNewswire
3 months ago
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Compare SXTP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SXTP 60 Degrees Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.